Navigation Links
Diabetes Research Institute Tests BioHub Mini Organ to Restore Natural Insulin Production in Type 1 Diabetes
Date:3/5/2013

MIAMI, Fla., March 5, 2013 /PRNewswire-USNewswire/ -- Scientists from the Diabetes Research Institute (DRI) at the University of Miami are taking a quantum leap toward a biological cure for diabetes by unveiling the DRI BioHub, a bioengineered "mini organ" that contains lifesaving insulin-producing cells that can sense blood sugar and release the precise amount of insulin needed in real time. The BioHub platform mimics the native pancreas and brings the promise of restoring natural insulin production and normalizing blood sugar levels in millions living with diabetes one step closer to reality.

(Photo: http://photos.prnewswire.com/prnh/20130305/DC70876)

(Logo:  http://photos.prnewswire.com/prnh/20120405/DC83112LOGO)

The DRI's research focus has been on developing a biological cure for diabetes by replacing the insulin-producing islets cells that have been mistakenly destroyed by the immune system in those with type 1 diabetes. Clinical trials have already shown that people with long-standing diabetes can achieve insulin independence after receiving infusions of islet cells from a donor organ. Some study patients continue to be insulin free for more than a decade post transplant.

However, islet transplantation has been limited to only the most severe cases of diabetes; several challenges still remain before the strategy can be offered to all who can benefit. The existing hurdles to be overcome include the need for  anti-rejection drugs that patients must take for life, the eventual need for  a plentiful supply of insulin-producing cells for transplant, and the identification of  an optimal site within the body to house the new cells. The BioHub is a platform that addresses these challenges by drawing on recent developments in bioengineering, immunol
'/>"/>

SOURCE Diabetes Research Institute Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
7. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
10. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014 The spinal column is one of the ... carried to and from the brain through the column control ... Injury or ailment here can be life altering, and leave ... control over their body. Though back injury and disease can ... are more options available to make things better than ever ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - The Canadian Epilepsy Alliance ... comic series designed to educate children about the most common ... Medikidz Explain Epilepsy comic series tells a fictional ... navigating middle school while living with epilepsy. ... there is still so much misinformation and lack of awareness ...
(Date:8/21/2014)... , N.Y. and HAMBURG, Germany , ... announced it is collaborating with Deutsches Elektronen-Synchrotron ( DESY ... Germany , to speed up management and storage ... Big Data and Analytics architecture based on IBM ... per second of data at peak performance and help ...
Breaking Medicine Technology:Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3
... ROCKVILLE, Md., Dec. 16, 2010 Novavax, Inc. (Nasdaq: ... clinical trial to evaluate a new vaccine candidate to prevent ... U.S. Food and Drug Administration (FDA) and is no longer ... had received a question from the FDA regarding chemistry, manufacturing ...
... Resources, one of the world,s leading research and ... that, owing to its superb efficacy, acceptable safety ... Ironwood/Forest/Almirall/Astellas,s linaclotide will emerge as the market leader ... In 2019, linaclotide will garner blockbuster sales of ...
Cached Medicine Technology:NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial 2NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial 3NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial 4For Treatment of Irritable Bowel Syndrome, Linaclotide Will Emerge as the Market Leader and Will Achieve Blockbuster Status in 2019 2
(Date:8/22/2014)... 22, 2014 Natural Clear Vision , ... restore his own vision from legally blind to perfect 20/20 ... investigative review. , “There is a huge portion of ... everyday function, and most people just think that’s the way ... surgery that can be pretty risky at times,” reports Michaels. ...
(Date:8/22/2014)... deletion in advanced non-small cell lung cancer (NSCLC) ... in epidermal growth factor receptor (EGFR) tyrosine kinase ... BIM deletion independently predicts overall survival (OS) of ... activate the programmed cell death also known as ... been detected in 12.8% of the Asian population ...
(Date:8/22/2014)... Rheumatoid arthritis (RA), a complex autoimmune disease that ... patients to not only cope with pain, disability ... as disrupted work, family life and marital functioning. ... residual pain and disability is common. In addition, ... high cost or side effects. Because of this, ...
(Date:8/22/2014)... London, UK (PRWEB) August 22, 2014 ... more magnetic for some clinical applications due to ... of the emerging innovations in ultrasound, such as ... imaging, are expected to keep the market moving ... as increasing mobility can enhance not only the ...
(Date:8/22/2014)... Mueller Sports Medicine is excited to ... new product that provides non-drug instant relief for plantar ... you heal. The package includes 7 days of relief, ... – it is not kinesiology tape. It’s made in ... for Plantar Fasciitis is a breakthrough in the ...
Breaking Medicine News(10 mins):Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:Deletion predicts survival in advanced non-small cell lung cancer 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2
... New York City has discovered that chronic pain occurs as ... colleagues were studying chronic pain at the molecular and cellular ... and the neurons becomes excited and begin to send signals ... the stimulus is removed the nerves become dormant and there ...
... mantids – that is, the female praying mantid eats ... possibility that males may also have something to gain ... In a paper in the August issue of The ... male risk-taking behavior in a praying mantis by altering ...
... facial transplant patient was discharged for a week after undergoing ... , ,Li Guoxing, 30, who had not seen his wife ... Xijing Hospital returned home Friday for a week-long visit to ... part of his face is alive and Li has been ...
... most common medical condition, chronic widespread pain is ... associated with fatigue, depression and poor sleep.// ... cancer patients deveolping FM like symptoms after treatment ... studies have shown contradictory results. A new study ...
... tested HIV positive was tied to his bedpost at the Meerut ... April after committing a robbery. He tested HIV positive only last ... College, which proved to be hopelessly inadequate to deal with his ... ago when a blood test confirmed he was HIV positive. He ...
... Alma Garcia, 41, were well aware of the toll ... was suffering from high blood pressure, diabetes and thyroid ... ,When they scheduled their gastric bypass surgeries at ... 2006, they joined a growing number of severely overweight ...
Cached Medicine News:Health News:Insufficent Anti-inflammatoy Proteins Leads to Chronic Pain 2Health News:Weight-Loss Surgeries Changing Lives 2Health News:Weight-Loss Surgeries Changing Lives 3Health News:Weight-Loss Surgeries Changing Lives 4
PosiBlot 30-30 Pads...
... VacuGene XL Vacuum Blotting System ... gels up to 20 30 ... Efficient and reproducible transfers improve blotting ... in the unit. Precise vacuum control ...
... Pens-Using a proprietary and patented technology, ADI ... called Antigen-Antibody pens-TM, that will allow researchers ... in any form or shape or size. ... to see antigen being written on the ...
... Advantages of using the Antigen-Antibody Pens-Using ... designed and developed specialized fountain pens, called ... deliver or write/mark the blotting membranes in ... specially formulated antigen-bonded colored dyes helps to ...
Medicine Products: